| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
|
Arch Intern Med
|
2006
|
3.91
|
|
2
|
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.
|
J Am Coll Cardiol
|
2011
|
2.83
|
|
3
|
Meta-analysis of statin effects in women versus men.
|
J Am Coll Cardiol
|
2012
|
2.56
|
|
4
|
Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
|
Circulation
|
2008
|
2.51
|
|
5
|
Expanding the definition and classification of hypertension.
|
J Clin Hypertens (Greenwich)
|
2005
|
2.35
|
|
6
|
J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial.
|
Eur Heart J
|
2010
|
2.32
|
|
7
|
Comprehensive stroke centers overcome the weekend versus weekday gap in stroke treatment and mortality.
|
Stroke
|
2011
|
2.01
|
|
8
|
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
Arch Intern Med
|
2005
|
1.99
|
|
9
|
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.
|
Circulation
|
2011
|
1.97
|
|
10
|
Cardiovascular protection using beta-blockers: a critical review of the evidence.
|
J Am Coll Cardiol
|
2007
|
1.76
|
|
11
|
Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative Dietary Modification Trial.
|
Am J Clin Nutr
|
2010
|
1.73
|
|
12
|
Long-term fatal outcomes in subjects with stroke or transient ischemic attack: fourteen-year follow-up of the systolic hypertension in the elderly program.
|
Stroke
|
2008
|
1.53
|
|
13
|
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine.
|
J Sex Med
|
2006
|
1.53
|
|
14
|
Aspirin use, dose, and clinical outcomes in postmenopausal women with stable cardiovascular disease: the Women's Health Initiative Observational Study.
|
Circ Cardiovasc Qual Outcomes
|
2009
|
1.48
|
|
15
|
Evening dosing of antihypertensive therapy to reduce cardiovascular events: a third type of evidence based on a systematic review and meta-analysis of randomized trials.
|
J Clin Hypertens (Greenwich)
|
2014
|
1.46
|
|
16
|
Hypertension guidelines: criteria that might make them more clinically useful.
|
Am J Hypertens
|
2002
|
1.45
|
|
17
|
Overview of phosphodiesterase 5 inhibition in erectile dysfunction.
|
Am J Cardiol
|
2003
|
1.39
|
|
18
|
Trends in mortality of acute myocardial infarction after discharge from the hospital.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
1.34
|
|
19
|
The effectiveness of outpatient appointment reminder systems in reducing no-show rates.
|
Am J Med
|
2010
|
1.27
|
|
20
|
Trends in incidence and mortality rates of ventricular septal rupture during acute myocardial infarction.
|
Am J Cardiol
|
2010
|
1.22
|
|
21
|
The relationship between cognitive function and physical performance in older women: results from the women's health initiative memory study.
|
J Gerontol A Biol Sci Med Sci
|
2009
|
1.21
|
|
22
|
Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
|
Am J Cardiol
|
2007
|
1.19
|
|
23
|
Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study.
|
Eur J Heart Fail
|
2006
|
1.19
|
|
24
|
Triggering of transmural infarctions, but not nontransmural infarctions, by ambient fine particles.
|
Environ Health Perspect
|
2010
|
1.18
|
|
25
|
Effect of anemia on 1-year mortality in patients with acute myocardial infarction.
|
Am Heart J
|
2002
|
1.11
|
|
26
|
ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension.
|
J Am Soc Hypertens
|
2011
|
1.09
|
|
27
|
Treating hypertension in the very old.
|
N Engl J Med
|
2008
|
1.08
|
|
28
|
Survival Differences in Clinical Trials With Long-Term Follow-Up.
|
J Am Coll Cardiol
|
2016
|
1.07
|
|
29
|
Cardiovascular manifestations of acute pancreatitis.
|
J Crit Care
|
2010
|
0.98
|
|
30
|
Refined ambient PM2.5 exposure surrogates and the risk of myocardial infarction.
|
J Expo Sci Environ Epidemiol
|
2013
|
0.97
|
|
31
|
Permanent pacing is a risk factor for the development of heart failure.
|
Am J Cardiol
|
2005
|
0.94
|
|
32
|
The triggering of myocardial infarction by fine particles is enhanced when particles are enriched in secondary species.
|
Environ Sci Technol
|
2013
|
0.93
|
|
33
|
Beyond hypertension toward guidelines for cardiovascular risk reduction.
|
Am J Hypertens
|
2004
|
0.92
|
|
34
|
Cardiopulmonary bypass has a modest association with cancer progression: a retrospective cohort study.
|
BMC Cancer
|
2013
|
0.92
|
|
35
|
Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study).
|
Am J Cardiol
|
2007
|
0.90
|
|
36
|
Persistence of mortality reduction after the end of randomized therapy in clinical trials of blood pressure-lowering medications.
|
Hypertension
|
2010
|
0.90
|
|
37
|
Cardiovascular drugs and cancer: of competing risk, smallpox, Bernoulli, and d'Alembert.
|
Eur Heart J
|
2012
|
0.88
|
|
38
|
Definition and classification of hypertension: an update.
|
J Clin Hypertens (Greenwich)
|
2009
|
0.86
|
|
39
|
Erectile dysfunction and cardiac disease: recommendations of the Second Princeton Conference.
|
Curr Urol Rep
|
2006
|
0.86
|
|
40
|
Effect of chlorthalidone, amlodipine, and lisinopril on visit-to-visit variability of blood pressure: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
|
J Clin Hypertens (Greenwich)
|
2014
|
0.85
|
|
41
|
Celebrating 50 years of experience: an ECFMG perspective.
|
Acad Med
|
2006
|
0.84
|
|
42
|
Dose doubling, relative potency, and dose equivalence of potassium-sparing diuretics affecting blood pressure and serum potassium: systematic review and meta-analyses.
|
J Hypertens
|
2016
|
0.84
|
|
43
|
Atrial fibrillation and isolated systolic hypertension: the systolic hypertension in the elderly program and systolic hypertension in the elderly program-extension study.
|
Hypertension
|
2008
|
0.82
|
|
44
|
Questionable hospital chart documentation practices by physicians.
|
J Gen Intern Med
|
2008
|
0.82
|
|
45
|
Quality of meta-analyses for randomized trials in the field of hypertension: a systematic review.
|
J Hypertens
|
2016
|
0.81
|
|
46
|
Heart rate and blood pressure response in adult men and women during exercise and sexual activity.
|
Am J Cardiol
|
2007
|
0.80
|
|
47
|
Not just chlorthalidone: evidence-based, single tablet, diuretic alternatives to hydrochlorothiazide for hypertension.
|
Curr Hypertens Rep
|
2015
|
0.79
|
|
48
|
Pharmacologic therapy for erectile dysfunction and its interaction with the cardiovascular system.
|
J Cardiovasc Pharmacol Ther
|
2013
|
0.79
|
|
49
|
Incidence and trends of heart failure admissions after coronary artery bypass grafting surgery.
|
Eur J Heart Fail
|
2012
|
0.78
|
|
50
|
Lifestyle management of erectile dysfunction: the role of cardiovascular and concomitant risk factors.
|
Am J Cardiol
|
2005
|
0.78
|
|
51
|
Continuation of mortality reduction after the end of randomized therapy in clinical trials of lipid-lowering therapy.
|
J Clin Lipidol
|
2011
|
0.77
|
|
52
|
Relationships between selected gene polymorphisms and blood pressure sensitivity to weight loss in elderly persons with hypertension.
|
Hypertension
|
2013
|
0.77
|
|
53
|
Leadership message. American Society of Hypertension-designated centers of excellence: a new initiative.
|
J Clin Hypertens (Greenwich)
|
2011
|
0.77
|
|
54
|
Cardiovascular outcomes after preeclampsia or eclampsia complicated by myocardial infarction or stroke.
|
Obstet Gynecol
|
2012
|
0.77
|
|
55
|
Statins and Cataracts--a visual insight.
|
Curr Atheroscler Rep
|
2015
|
0.76
|
|
56
|
Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting.
|
Arch Intern Med
|
2002
|
0.76
|
|
57
|
Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association.
|
Circulation
|
2016
|
0.75
|
|
58
|
Erectile dysfunction and incidence of cardiovascular disease.
|
JAMA
|
2006
|
0.75
|
|
59
|
Treating hypercholesterolemia and hypertension based on lifetime global risk.
|
Am J Cardiol
|
2007
|
0.75
|
|
60
|
Fibrinogen and coronary artery disease.
|
Hellenic J Cardiol
|
2010
|
0.75
|
|
61
|
Diagnostic evaluation: target organ damage - cardiovascular.
|
J Am Soc Hypertens
|
2014
|
0.75
|
|
62
|
Expertise: no longer a sine qua non for guideline authors?
|
J Hypertens
|
2017
|
0.75
|
|
63
|
Clinical Application of Biomarkers in Heart Failure with a Preserved Ejection Fraction: A Review.
|
Cardiology
|
2016
|
0.75
|
|
64
|
Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Low-Intermediate Surgical Risk Patients: A Systematic Review and Meta-Analysis.
|
J Invasive Cardiol
|
2017
|
0.75
|
|
65
|
Reply.
|
J Hypertens
|
2017
|
0.75
|
|
66
|
Age-neutral guidelines for the primary prevention of cardiovascular disease.
|
J Clin Hypertens (Greenwich)
|
2009
|
0.75
|
|
67
|
Reduction of stroke risk factors.
|
J Clin Hypertens (Greenwich)
|
2007
|
0.75
|
|
68
|
Immediate and 1-year survival of out-of-hospital cardiac arrest victims in southern New Jersey: 1995-2000.
|
Pacing Clin Electrophysiol
|
2004
|
0.75
|
|
69
|
Treatment of octogenarians: should we and how.
|
J Clin Hypertens (Greenwich)
|
2004
|
0.75
|
|
70
|
Atrial fibrillation registries, administrative databases, clinical trials, and outcomes.
|
Am J Cardiol
|
2011
|
0.75
|
|
71
|
Comparison of hospital versus out of hospital coronary death rates in women and men.
|
Am J Cardiol
|
2010
|
0.75
|